In our trial, 12 weeks of NMES at 35 Hz statistically and significantly reduced the blood concentrations of glycated hemoglobin, total and low-density cholesterol in T2DM patients with post-stroke hemiplegia, who had been on stabilized therapy with insulin, hypotensive drugs, and antihyperlipidemic agents. The gene discussed is INS; the disease is Stroke.